Close

Drug Research

UK Begins The Biggest Immunization Program In Its History

The UK has begun immunizing citizens against Coronavirus. Population above 80, the most vulnerable and the front line health care workers to be administered with the Pfizer COVID-19 vaccine in the first phase. There is a history in the...

Russia Begins Sputnik V Coronavirus Vaccine Distribution

Sputnik V has been rolled out in Moscow and will be subsequently distributed across other Russian cities. One needs to see if this will halt the growing number of COVID-19 cases in the country. Sputnik V to be...

KaliVir Immunotherapeutics, Astellas ink research agreement to develop and commercialise VET2-L2 novel oncolytic virus

KaliVir Immunotherapeutics LLC and Astellas Pharma Inc announced that they entered into a worldwide licensing agreement for the research, development, and commercialization of VET2-L2, an intravenously administered oncolytic virus for Immuno-Oncology, as well as a research collaboration to generate...

Catalent to Invest $10 Million to Expand High Potency Containment Capabilities for Micronization

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it is investing $10 million in isolator capabilities at its sites in Malvern,...

Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab for COVID-19

Eli Lilly and Company and UnitedHealth Group announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals. Bamlanivimab recently received EUA by the U.S. FDA for the treatment of mild to moderate COVID-19 patients...

Rush For A COVID Vaccine- Is It Science Or Politics…?

COVID-19 vaccine usage announcement by the UK has brought us to the brink where other countries too might jump on the bandwagon. Is it safe or are we rushing into things? We only hope that science triumphs over politics. Are...

Batavia and KU Leuven join forces to accelerate development of highly promising COVID-19 vaccine candidate

KU Leuven, a leading research institution and one of the top 50 universities in the world and Batavia Biosciences, a contract development and manufacturing organization focused on delivering sustainable manufacturing solutions in the field of vaccines and oncology, announce...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read